Race Oncology (ASX: RAC) 2023 Annual General Meeting
Race Oncology (ASX: RAC) 2023 Annual General Meeting
The Race Oncology Annual General Meeting was held on Monday 27 November 2023. During the meeting the Race Board and management team provided an update on the forward-looking strategy, detailed new clinical development plans...
March 2023 Update
March 2023 Update
Race Oncology Limited (“Race”) announces Executive Director and Chief Scientific Officer (CSO), Dr Daniel Tillett has advised his decision to step down from his roles. Dr Tillett will provide ongoing support through June 2023...
December 2022 Update
December 2022 Update
Race is pleased to announce the appointment of global pharmaceutical and commercial leader, Mr Damian Clarke-Bruce, as Managing Director and Chief Executive Officer, effective 1 February 2023. Mr Phil Lynch will return to his...
Race Submits Human Ethics Application to Commence Cardioprotection Breast Cancer Trial
Race Develops Improved IV Formulation of Zantrene
Race Develops Improved IV Formulation of Zantrene
To discuss or comment on this announcement please visit our Investor Hub....
Race Initiates FTO & ALKBH5 Drug Discovery Program
Race Initiates FTO & ALKBH5 Drug Discovery Program
To discuss or comment on this announcement please visit our Investor Hub....
Race Oncology 2022 Annual Report
June 2022 Quarterly Activity Report
Zantrene Protects Mouse Hearts from Chemotherapy Damage
Zantrene Protects Mouse Hearts from Chemotherapy Damage
30 June 2022 – Race Oncology Limited (“Race”) is pleased to share further interim results from our preclinical cardioprotection program in collaboration with researchers from the University of Newcastle (ASX announcement: 28 April 2021)....
Zantrene shows impressive synergy with BRAF & MEK inhibitors in treating melanoma
Zantrene shows impressive synergy with BRAF & MEK inhibitors in treating melanoma
28 June 2022 – Race Oncology Limited (“Race”) is pleased to share the final results from our preclinical melanoma research program in collaboration with the University of Newcastle (ASX announcement: 19 March 2021). This...
